Literature DB >> 25778330

Polymorphisms of GSTA1 contribute to elevated cancer risk: evidence from 15 studies.

Qiwen Deng1, Bangshun He, Yuqin Pan, Huiling Sun, Xian Liu, Jie Chen, Houqun Ying, Kang Lin, Hongxin Peng, Shukui Wang.   

Abstract

PURPOSE: Glutathione S-transferases (GSTs) are involved in the detoxification of carcinogens, and may be linked to carcinogenesis. As a vital component of GSTs, GSTA1 plays an important role in carcinogenesis. However, the studies about the effect of GSTA1 polymorphisms on cancer risk are limited and the conclusions are contradictory. This meta-analysis aimed to evaluate the association between GSTA1 polymorphisms (-567T>G, (69C>T and -52G>A) and cancer risk.
METHODS: A literature search of PubMed and Web of Science databases was conducted from their inception through December 2013. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the association of GSTA1 polymorphisms and cancer risk.
RESULTS: A total of 15 studies were enrolled, and the results indicated that GSTA1 BB genotype was associated with elevated cancer risk, especially in colorectal cancer. Further stratifications showed that GSTA1 BB genotype was associated with increased cancer risk in Caucasian populations and in the study with population-based controls.
CONCLUSIONS: This meta-analysis suggested that GSTA1 BB genotype was a risk factor for colorectal cancer, especially in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25778330

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  8 in total

1.  Glutathione-s-transferase A 4 (GSTA4) suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting AKT pathway.

Authors:  Chang Jun Liu; Jin Hui Yang; Fei Zhou Huang; Wan Pin Nie; Chu Ping Liu; Xian Hai Mao; Xin Min Yin; Xian Bo Shen; Chuang Peng; Mei Fu Chen; Bo Jiang; Xun Yang Liu; Jin Shu Wu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Downregulation of Glutathione S-transferase A1 suppressed tumor growth and induced cell apoptosis in A549 cell line.

Authors:  Huan Liu; Zhouping Yang; Linquan Zang; Guixiang Wang; Sigui Zhou; Guifang Jin; Zhicheng Yang; Xuediao Pan
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

3.  Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.

Authors:  Milica Lj Stojkovic Lalosevic; Vesna M Coric; Tatjana D Pekmezovic; Tatjana P Simic; Marija S Pljesa Ercegovac; Aleksandra R Pavlovic Markovic; Zoran V Krivokapic
Journal:  Pathol Oncol Res       Date:  2019-01-29       Impact factor: 3.201

4.  The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals.

Authors:  Hanane Akhdar; Said El Shamieh; Orlando Musso; Romain Désert; Wissam Joumaa; Dominique Guyader; Caroline Aninat; Anne Corlu; Fabrice Morel
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.

Authors:  Dong Gui Hu; Ross A McKinnon; Julie-Ann Hulin; Peter I Mackenzie; Robyn Meech
Journal:  Int J Mol Sci       Date:  2016-12-27       Impact factor: 5.923

Review 6.  Glutathione S-transferase π: a potential role in antitumor therapy.

Authors:  Shu-Chen Dong; Huan-Huan Sha; Xiao-Yue Xu; Tian-Mu Hu; Rui Lou; Huizi Li; Jian-Zhong Wu; Chen Dan; Jifeng Feng
Journal:  Drug Des Devel Ther       Date:  2018-10-23       Impact factor: 4.162

7.  The analysis of GSTA1 promoter genetic and functional diversity of human populations.

Authors:  Tiago Nava; Marc Ansari; Vid Mlakar; Patricia Huezo-Diaz Curtis; Marc Armengol; Victor Ythier; Isabelle Dupanloup; Khalil Ben Hassine; Laurence Lesne; Rabih Murr; Simona Jurkovic Mlakar
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

8.  Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane.

Authors:  Irina Teslenko; Julia Trudeau; Shaman Luo; Christy J W Watson; Gang Chen; Cristina I Truica; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2022-07-06       Impact factor: 4.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.